Modifier 25 in 2027: What CMS's Proposed Payment Cut Means for Physicians

Introduction

If your practice regularly bills a same-day office visit alongside a minor procedure, you've probably already heard something about this, even if the details are still fuzzy. CMS released the CY 2027 Medicare Physician Fee Schedule proposed rule in July 2026, and buried inside it is a provision that would cut Medicare payment in half on a huge number of the encounters procedural specialties bill every single day.

This isn't a minor technical adjustment. It's a proposal that directly touches modifier 25, one of the most commonly used, and most commonly scrutinized, modifiers in outpatient medicine. This article walks through exactly what CMS is proposing, why the agency wants to make this change, why physician organizations are actively pushing back against it, and what your practice should be reviewing right now while there's still time to act.

What Exactly Is CMS Proposing?

Under the proposed rule, CMS would reduce Medicare payment when a physician, or another physician in the same group practice, bills a separately identifiable office or outpatient evaluation and management visit with modifier 25 on the same day as a procedure carrying a 0-day, 10-day, or 90-day global period.

Here's how the mechanics actually work. The single most expensive qualifying service billed that day, which could be either the E/M visit or the procedure, would be paid at 100 percent. Every other qualifying service billed on that same date, whether that's an additional procedure or the E/M visit itself, would be paid at only 50 percent.

This is important to understand clearly: CMS is not proposing to eliminate modifier 25. The modifier still exists, the E/M visit is still separately reportable, and the documentation standard for using it correctly doesn't change under this proposal. What changes is the reimbursement amount on whichever of the two services isn't the highest-valued one that day.

Is the 50 Percent Payment Cut Final?

No, and this is worth stating plainly because a lot of the anxiety circulating about this proposal treats it as though it's already locked in. It isn't. This is a proposed rule, not a final one. CMS published it on July 15, 2026, and is accepting public comments through September 14, 2026. A final rule is expected later in the fall of 2026, with any finalized changes taking effect January 1, 2027, if CMS moves forward with them.

There's also useful historical context here. CMS floated a similar idea back in the 2019 Physician Fee Schedule proposed rule, at that time limited to procedures with a 0-day global period. It didn't survive to the final rule. Commenters pushed back hard, arguing that modifier 25 itself already certifies that the visit is significant and separately identifiable, and that the AMA's RVS Update Committee process already accounts for any overlap when valuing codes. CMS ultimately shelved that version in 2019 to let broader E/M coding reform work through first.

The 2027 version is a broader proposal than what CMS tried in 2019. It now covers 0-day, 10-day, and 90-day global periods, not just 0-day procedures, and it ties the payment reduction directly to the Multiple Procedure Payment Reduction framework CMS already uses elsewhere in the fee schedule.

Why Does CMS Want to Make This Change?

CMS's stated rationale centers on resource overlap between a global surgical package and a same-day, separately billed E/M visit. Global surgery packages are built to cover pre-operative, intra-operative, and post-operative work tied to a procedure, and that valuation already includes a certain amount of visit-related physician work baked into the procedure code's own relative value units.

CMS's position is that when a separately identifiable E/M visit is also billed on that same day, there's likely duplication between the work already accounted for in the global package and the work being billed separately through the E/M visit with modifier 25 attached. The proposed 50 percent reduction is CMS's attempt to address that perceived overlap at the payment level, across the board, rather than evaluating it code by code.

Why Are Physicians and Medical Organizations Opposing It?

The opposition has been fast and organized. The American Medical Association, joined by numerous specialty societies in a formal Federation comment letter responding to the proposed rule, has urged CMS not to finalize the 50 percent reduction, not to extend the policy to inpatient or other E/M services, and instead to address any genuine overlap through the existing misvalued code process and RUC valuation review on a code-specific basis, rather than through a blanket, uniform payment cut.

The core of the pushback is that CMS is advancing this policy, in the AMA's own words, on an unsubstantiated assumption of likely duplication, without the kind of evidence a change of this magnitude would typically require, and without addressing the same concerns that led the agency to decline a substantially similar proposal back in 2019.

The practical concern underneath the policy argument is straightforward. Modifier 25 is used constantly, and legitimately, across dermatology, ophthalmology, orthopedics, OB/GYN, podiatry, family medicine, and urgent care, among others, precisely because patients frequently need both an evaluation and a same-day procedure for a genuinely separate, distinct reason. Physician organizations argue that a uniform payment cut punishes that legitimate, everyday clinical pattern instead of targeting the narrower set of situations where genuine overlap might actually exist.

What Modifier 25 Means and When It's Used

Modifier 25 identifies a significant, separately identifiable evaluation and management service performed by the same physician or qualified healthcare professional on the same day as another procedure or service. Current Medicare policy allows separate payment for that E/M visit when it genuinely meets this standard and the medical record supports the additional work involved.

What "separately identifiable" actually means

The E/M service has to represent work above and beyond the usual pre-procedure evaluation that's already built into the procedure's own valuation. A classic, legitimate example is a patient presenting for a scheduled procedure who also raises a new, unrelated concern that requires its own evaluation and medical decision making. Another common scenario is a patient whose visit starts as a routine evaluation, and during that same encounter, a minor in-office procedure becomes appropriate based on findings from the exam.

Why this modifier draws so much payer scrutiny already

Even before this proposed change, modifier 25 has long been one of the most closely reviewed modifiers in Medicare and commercial billing, precisely because it's high volume and because the line between "genuinely separate" and "routine pre-procedure evaluation" isn't always obvious from a quick claims review. That existing scrutiny is exactly why documentation quality matters so much, and why it matters even more under this proposal.

Why Clinical Documentation Matters More Than Ever

Nothing about the documentation standard for modifier 25 changes under this proposal. What changes is the financial stakes riding on that documentation being airtight.

1. The note needs to clearly separate the E/M-supporting work from the procedure-supporting work, rather than blending them into one undifferentiated narrative.
2. Medical necessity for the E/M visit needs to stand on its own, independent of the procedure performed that same day.
3. If the E/M visit addressed a distinct problem unrelated to the procedure, that distinction needs to be explicit in the documentation, not something a reviewer has to infer.
4. If the procedure itself arose from findings during the E/M evaluation, the clinical reasoning connecting the two needs to be clear enough that a reviewer understands why both were medically necessary and separately identifiable. Documentation improvement support can help practices strengthen these workflows before payer scrutiny increases.

Given that payers already scrutinize modifier 25 closely, and given that this proposal would put real money behind getting the underlying valuation questions right, documentation that was previously "good enough" to avoid a denial may not be strong enough to avoid an audit flag once more financial weight sits on the same-day billing pattern.

How Could This Affect Medicare Reimbursement?

This is where a common misunderstanding trips people up, so it's worth being precise. A lot of physicians hearing about this proposal assume the cut lands on the procedure. In most modifier 25 scenarios, that's backward. The E/M visit is typically the lower-valued of the two services billed that day, which means under this proposal, it's usually the E/M visit that gets reduced to 50 percent, not the procedure.

Across a single encounter, that reduction might not sound dramatic. Across hundreds or thousands of Medicare encounters over the course of a year for a busy procedural practice, a 50 percent reduction to one qualifying service on that many claims could add up to a material, ongoing change in annual reimbursement. The exact financial impact depends heavily on how frequently a specific practice bills this combination, and which specific procedure and E/M code pairs show up most often in that practice's claims history.

Which Specialties and Practices Should Pay Attention

Any practice that bills a separately identifiable E/M visit on the same day as a procedure carrying a global period should be watching this closely, but a few specialties carry disproportionately high modifier 25 volume and should be paying especially close attention.

1. Dermatology, where same-day biopsies, excisions, and lesion removals alongside a separate evaluation are routine.
2. Ophthalmology, given how frequently in-office procedures follow directly from same-day evaluation findings.
3. Orthopedics, where injections, aspirations, and minor procedures commonly accompany an E/M visit.
4. OB/GYN, particularly gynecology, where colposcopy, biopsy, and IUD placement frequently pair with a same-day office visit.
5. Podiatry, where nail and skin procedures are commonly billed alongside an evaluation.
6. Family medicine and urgent care, where the sheer volume of same-day minor procedures paired with evaluation visits is substantial even though any individual encounter's dollar impact is smaller.

What Billing and Coding Teams Should Review Before 2027

1. Pull historical claims data to see exactly how often your practice bills Medicare E/M services with modifier 25, and which specific procedure codes most commonly appear alongside them. A coding accuracy review can also help identify recurring modifier 25 patterns that may need closer attention.
2. Model the potential financial impact by provider, location, and specialty, using your own claims history rather than industry averages, since modifier 25 volume varies enormously by practice type.
3. Review your commercial payer policies separately, since modifier 25 reimbursement rules already vary among private insurers, and some commercial payers have already implemented their own same-day payment reductions independent of anything CMS does.
4. Strengthen documentation templates now for your highest-volume modifier 25 code pairs, so the medical necessity and separateness of each service is unambiguous in the chart.
5. Consider submitting a comment to CMS before the September 14, 2026 deadline if this proposal poses a material risk to your practice, since the comment period is the formal mechanism for practices and specialty societies to influence the final rule.

Common Misconceptions About This Proposal

1. Assuming the procedure takes the cut. In most modifier 25 scenarios, the E/M visit is the lower-valued service, so it's typically the E/M that gets reduced to 50 percent, not the procedure.
2. Assuming modifier 25 is being eliminated. It isn't. The modifier still exists, the E/M is still separately billable, and the documentation standard hasn't changed. What's proposed is a payment reduction on the lesser-valued service, not a ban on billing it.
3. Treating this as a finalized rule. It's a proposal. CMS pulled back a similar 2019 version after strong public comment, and specialty societies have already formally opposed this version too.
4. Assuming this only affects surgical specialties. Family medicine and urgent care practices bill enormous volumes of lower-dollar modifier 25 encounters, and the cumulative impact across high volume can matter just as much as fewer, higher-dollar encounters in a surgical specialty.

Expert Recommendations

The practices coming into this proposal well prepared are the ones treating it as a modeling exercise now, not a wait-and-see situation. Pulling your own claims data and understanding your specific exposure, which procedure and E/M pairs you bill most often, and what a 50 percent reduction on the lower-valued side of those pairs would actually mean for your annual Medicare revenue, gives you a real number to plan around rather than a vague sense of concern.

It's also worth remembering that this exact proposal was defeated once before, in 2019, largely because of organized, substantive public comment from physician groups. If your practice or specialty society has data showing that your specific modifier 25 usage reflects genuinely separate, medically necessary work rather than duplicative billing, that's precisely the kind of evidence CMS's comment process is designed to weigh, and precisely the kind of pushback that worked the last time this idea came up.

Finally, regardless of how the final rule lands, tightening modifier 25 documentation now is good practice on its own merits. This modifier already draws more payer scrutiny than most, and a stronger documentation habit protects your practice against today's audit risk while also positioning you well for whatever CMS ultimately finalizes.

What Happens Next

The public comment period for the CY 2027 Physician Fee Schedule proposed rule runs through September 14, 2026. After that, CMS will review the comments received, which for a provision this contested will likely include substantial input from the AMA, specialty societies, and individual practices, before issuing a final rule. Based on CMS's typical annual rulemaking cycle, that final rule is expected sometime in the fall of 2026, with any finalized provisions taking effect January 1, 2027.

Watch specifically for whether CMS finalizes the 50 percent reduction as proposed, scales it back, narrows it to a specific subset of code pairs, or, as happened with the similar 2019 proposal, declines to finalize it at all in favor of addressing overlap through the existing code-specific valuation process instead.

Frequently Asked Questions

What exactly is CMS proposing for modifier 25 in 2027?

CMS is proposing to reduce Medicare payment by 50 percent on the lower-valued of two same-day services when a separately identifiable E/M visit is billed with modifier 25 alongside a procedure carrying a 0-day, 10-day, or 90-day global period. The highest-valued service that day would still be paid at 100 percent.

Is the 50 percent payment cut final?

No. This is a proposed rule published July 15, 2026, with public comments accepted through September 14, 2026. A final rule is expected in the fall of 2026, and any finalized changes would take effect January 1, 2027.

Why does CMS want to make this change?

CMS believes there may be resource overlap between the visit-related work already built into a global surgical package's valuation and a separately billed, same-day E/M visit, and the proposed payment reduction is intended to address that perceived duplication.

Why are physicians opposing it?

The AMA and numerous specialty societies, in a formal comment letter, argue CMS is proposing this change based on an unsubstantiated assumption of duplication, without adequate evidence, and that any genuine overlap should be addressed through the existing code-specific misvalued code and RUC valuation process rather than a uniform, across-the-board payment cut.

How could this affect Medicare reimbursement?

In most modifier 25 scenarios, the E/M visit is the lower-valued service, so it's typically the E/M visit, not the procedure, that would be reduced to 50 percent payment under this proposal. Across high claim volume, that reduction could represent a material change in annual Medicare revenue for practices that bill this combination frequently.

What does documentation have to prove when modifier 25 is used?

Documentation needs to clearly establish that the E/M visit represents significant, separately identifiable work beyond the routine pre-procedure evaluation already accounted for in the procedure's valuation, with medical necessity for the E/M visit standing independently from the procedure performed that same day.

What should practices review before 2027?

Practices should pull historical claims data on modifier 25 usage, model the potential financial impact of the proposed reduction using their own billing patterns, review commercial payer policies separately, and strengthen documentation for their highest-volume modifier 25 code pairs.

Has CMS proposed something like this before?

Yes. A similar proposal appeared in the CY 2019 Physician Fee Schedule proposed rule, limited to 0-day global procedures at the time. It was not finalized after strong opposition from physician organizations, and CMS shelved it to let broader E/M coding reform proceed first.

Which specialties bill modifier 25 most frequently?

Dermatology, ophthalmology, orthopedics, OB/GYN, podiatry, family medicine, and urgent care carry particularly high modifier 25 volume, given how often same-day evaluation and minor procedures occur together in these specialties.

What should doctors and billing teams watch for when CMS releases the final rule?

Watch for whether CMS finalizes the 50 percent reduction exactly as proposed, narrows it to specific code pairs, scales back the percentage, or declines to finalize the provision altogether, as happened with the similar 2019 proposal after public comment.

Conclusion

CMS's proposed modifier 25 payment reduction is a real, substantive threat to a billing pattern that procedural and primary care practices alike rely on constantly, and it deserves to be taken seriously rather than dismissed as background regulatory noise. But it's also, as of this writing, still a proposal, not a finalized policy, and the same organized physician pushback that defeated a similar idea in 2019 is already underway for this version. The practices in the best position, regardless of how the final rule lands, are the ones that understand their own modifier 25 exposure now, have already tightened their documentation, and aren't caught off guard whichever way this goes.

Edge RCM CTA

Whether this proposal is finalized as written, scaled back, or withdrawn entirely, modifier 25 documentation and coding accuracy matter right now, given how closely this modifier is already reviewed. Edge RCM works with practices on modifier usage audits, documentation strengthening, and claims impact modeling, helping you understand your specific exposure to this proposal and tighten your billing process regardless of the outcome. If your practice bills a meaningful volume of same-day E/M and procedure claims, Edge RCM can help you get ahead of this before the final rule lands.